Top Key Companies for Metabolomics Market: Thermo Fisher, Agilent, Metabolon, Shimadzu Corporation, Bruker, Waters Corporation, Biotree, LECO Corporation, Biocrates Life Sciences AG, Human Metabolome Technologies, Metware, Applied Protein Technology, Creative Proteomics, Diagnostic Solutions Laboratory.
Global Metabolomics Market Size was estimated at USD 404.3 million in 2022 and is projected to reach USD 523.49 million by 2028, exhibiting a CAGR of 4.4% during the forecast period.
Global Metabolomics Market Overview And Scope:
The Global Metabolomics Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Metabolomics utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Metabolomics Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabolomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Metabolomics market.
Global Metabolomics Market Segmentation
By Type, Metabolomics market has been segmented into:
Metabolomics Instruments
Bioinformatics Tools and Services
By Application, Metabolomics market has been segmented into:
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Regional Analysis of Metabolomics Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Metabolomics Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Metabolomics market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Metabolomics market.
Top Key Companies Covered in Metabolomics market are:
Thermo Fisher
Agilent
Metabolon
Shimadzu Corporation
Bruker
Waters Corporation
Biotree
LECO Corporation
Biocrates Life Sciences AG
Human Metabolome Technologies
Metware
Applied Protein Technology
Creative Proteomics
Diagnostic Solutions Laboratory
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Metabolomics Market by Type
5.1 Metabolomics Market Overview Snapshot and Growth Engine
5.2 Metabolomics Market Overview
5.3 Metabolomics Instruments
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Metabolomics Instruments: Geographic Segmentation
5.4 Bioinformatics Tools and Services
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Bioinformatics Tools and Services: Geographic Segmentation
Chapter 6: Metabolomics Market by Application
6.1 Metabolomics Market Overview Snapshot and Growth Engine
6.2 Metabolomics Market Overview
6.3 Academic and Research Institutes
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Academic and Research Institutes: Geographic Segmentation
6.4 Pharmaceutical and Biotechnology Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical and Biotechnology Companies: Geographic Segmentation
6.5 Contract Research Organizations
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Contract Research Organizations: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Metabolomics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Metabolomics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Metabolomics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 THERMO FISHER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 AGILENT
7.4 METABOLON
7.5 SHIMADZU CORPORATION
7.6 BRUKER
7.7 WATERS CORPORATION
7.8 BIOTREE
7.9 LECO CORPORATION
7.10 BIOCRATES LIFE SCIENCES AG
7.11 HUMAN METABOLOME TECHNOLOGIES
7.12 METWARE
7.13 APPLIED PROTEIN TECHNOLOGY
7.14 CREATIVE PROTEOMICS
7.15 DIAGNOSTIC SOLUTIONS LABORATORY
Chapter 8: Global Metabolomics Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Metabolomics Instruments
8.2.2 Bioinformatics Tools and Services
8.3 Historic and Forecasted Market Size By Application
8.3.1 Academic and Research Institutes
8.3.2 Pharmaceutical and Biotechnology Companies
8.3.3 Contract Research Organizations
Chapter 9: North America Metabolomics Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Metabolomics Instruments
9.4.2 Bioinformatics Tools and Services
9.5 Historic and Forecasted Market Size By Application
9.5.1 Academic and Research Institutes
9.5.2 Pharmaceutical and Biotechnology Companies
9.5.3 Contract Research Organizations
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Metabolomics Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Metabolomics Instruments
10.4.2 Bioinformatics Tools and Services
10.5 Historic and Forecasted Market Size By Application
10.5.1 Academic and Research Institutes
10.5.2 Pharmaceutical and Biotechnology Companies
10.5.3 Contract Research Organizations
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Metabolomics Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Metabolomics Instruments
11.4.2 Bioinformatics Tools and Services
11.5 Historic and Forecasted Market Size By Application
11.5.1 Academic and Research Institutes
11.5.2 Pharmaceutical and Biotechnology Companies
11.5.3 Contract Research Organizations
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Metabolomics Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Metabolomics Instruments
12.4.2 Bioinformatics Tools and Services
12.5 Historic and Forecasted Market Size By Application
12.5.1 Academic and Research Institutes
12.5.2 Pharmaceutical and Biotechnology Companies
12.5.3 Contract Research Organizations
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Metabolomics Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Metabolomics Instruments
13.4.2 Bioinformatics Tools and Services
13.5 Historic and Forecasted Market Size By Application
13.5.1 Academic and Research Institutes
13.5.2 Pharmaceutical and Biotechnology Companies
13.5.3 Contract Research Organizations
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Metabolomics Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Metabolomics Instruments
14.4.2 Bioinformatics Tools and Services
14.5 Historic and Forecasted Market Size By Application
14.5.1 Academic and Research Institutes
14.5.2 Pharmaceutical and Biotechnology Companies
14.5.3 Contract Research Organizations
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Metabolomics Scope:
|
Report Data
|
Metabolomics Market
|
|
Metabolomics Market Size in 2025
|
USD XX million
|
|
Metabolomics CAGR 2025 - 2032
|
XX%
|
|
Metabolomics Base Year
|
2024
|
|
Metabolomics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher, Agilent, Metabolon, Shimadzu Corporation, Bruker, Waters Corporation, Biotree, LECO Corporation, Biocrates Life Sciences AG, Human Metabolome Technologies, Metware, Applied Protein Technology, Creative Proteomics, Diagnostic Solutions Laboratory.
|
|
Key Segments
|
By Type
Metabolomics Instruments
Bioinformatics Tools and Services
By Applications
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
|
